FDA Inspection
Cadila Pharmaceuticals LimitedCadila Pharmaceuticals Limited – FDA Inspection, Aug 9, 2019
Record Details
This FDA Inspection record concerns Cadila Pharmaceuticals Limited, with an inspection on August 9, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c46cb87f-671f-483c-a547-23b179476c00
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1102381
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Cadila Pharmaceuticals Limited
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 10, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 13, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 25, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 28, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 11, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cadila Pharmaceuticals Limited
- FDA Inspection 1239090 - 2024-05-10
- FDA Inspection 1044877 - 2018-02-13
- FDA Inspection 982066 - 2016-07-25
- FDA Inspection 873262 - 2014-03-28
- FDA Inspection 664596 - 2009-12-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.